Dally Therapeutics srl is an Italian innovative start-up founded in 2022 in Turin, Italy.

We develop technology solutions to support diabetes management. The main product is Dally, a mobile application that supports people in diabetes management, education and monitoring, providing 360° support.

The team is young, interdisciplinary and motivated with the goal of making life as easy as possible for people with diabetes. Our Mission is to improve the quality of life of people with diabetes by providing simple, safe and innovative support.

While there are many generalist wellness apps in the market, the Dally team immediately focused on the creation of a clinically validated and certified technology that integrates with traditional therapies, improving the overall quality of health care in the long run. In fact, the goal is to recognize Dally as software as medical device and conduct the clinical studies in collaboration with hospitals and other stakeholders to clinically and scientifically validate the developed solution.